ATE202799T1 - Hybride proteinkomplexe, betreffendes herstellungsverfahren, und ihre anwendungen in der diagnostik, als therapeutische agens oder reaktionsmittel, das in der medizin verwendung findet - Google Patents
Hybride proteinkomplexe, betreffendes herstellungsverfahren, und ihre anwendungen in der diagnostik, als therapeutische agens oder reaktionsmittel, das in der medizin verwendung findetInfo
- Publication number
- ATE202799T1 ATE202799T1 AT93400323T AT93400323T ATE202799T1 AT E202799 T1 ATE202799 T1 AT E202799T1 AT 93400323 T AT93400323 T AT 93400323T AT 93400323 T AT93400323 T AT 93400323T AT E202799 T1 ATE202799 T1 AT E202799T1
- Authority
- AT
- Austria
- Prior art keywords
- applications
- protein complexes
- diagnostics
- medicine
- hybrid protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9201505A FR2687157B1 (fr) | 1992-02-11 | 1992-02-11 | Proteines hybrides complexes, leur procede de preparation, et leurs applications comme agent de diagnostic, comme agent a visee therapeutique ou comme reactif utilisable en imagerie medicale. |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE202799T1 true ATE202799T1 (de) | 2001-07-15 |
Family
ID=9426518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT93400323T ATE202799T1 (de) | 1992-02-11 | 1993-02-09 | Hybride proteinkomplexe, betreffendes herstellungsverfahren, und ihre anwendungen in der diagnostik, als therapeutische agens oder reaktionsmittel, das in der medizin verwendung findet |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0556111B1 (de) |
JP (1) | JPH06277092A (de) |
AT (1) | ATE202799T1 (de) |
CA (1) | CA2089139A1 (de) |
DE (1) | DE69330390T2 (de) |
FR (1) | FR2687157B1 (de) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4860702B2 (ja) | 2005-10-21 | 2012-01-25 | エフ.ホフマン−ラ ロシュ アーゲー | ポリペプチドのリコンビナント発現のための方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2648713B1 (fr) * | 1989-06-26 | 1994-06-10 | Commissariat Energie Atomique | Proteines hybrides entre une enzyme extracytoplasmique et une autre proteine, leur procede de preparation, ainsi que leur application comme agent de diagnostic |
-
1992
- 1992-02-11 FR FR9201505A patent/FR2687157B1/fr not_active Expired - Fee Related
-
1993
- 1993-02-09 DE DE69330390T patent/DE69330390T2/de not_active Expired - Fee Related
- 1993-02-09 EP EP93400323A patent/EP0556111B1/de not_active Expired - Lifetime
- 1993-02-09 AT AT93400323T patent/ATE202799T1/de not_active IP Right Cessation
- 1993-02-09 CA CA002089139A patent/CA2089139A1/en not_active Abandoned
- 1993-02-12 JP JP5024368A patent/JPH06277092A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
FR2687157A1 (fr) | 1993-08-13 |
DE69330390T2 (de) | 2002-10-17 |
FR2687157B1 (fr) | 1995-10-06 |
JPH06277092A (ja) | 1994-10-04 |
EP0556111B1 (de) | 2001-07-04 |
DE69330390D1 (de) | 2001-08-09 |
CA2089139A1 (en) | 1993-08-12 |
EP0556111A1 (de) | 1993-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Elton et al. | Psychological control of pain. | |
Starfield et al. | Effectiveness of pediatric care: the relationship between processes and outcome | |
EP0671920A4 (de) | Ein anti-idiotypischer antikörper und seine verwendung in der diagnose und therapie von hiv-verwandten krankheiten. | |
DE3686361D1 (de) | Verwendung von bismuth zur herstellung von medikamenten zur behandlung von magen-darmstoerungen, die von campylobacter polyridis verursacht sind. | |
DE69031410D1 (de) | Monoklonale Antikörper gegen den humanen alpha/beta-T-Zellenrezeptor, ihre Herstellung und Verwendung | |
DE69633717D1 (de) | Monoklonale anti-cd6 antikörper zur behandlung und diagnose von psoriasis | |
DE69020007D1 (de) | Vernetzte Antikörper und Verfahren zu ihrer Herstellung. | |
DE69533942D1 (de) | Behandlung von lösungen roter blutkörperchen mit antiviralen wirkstoffen | |
DE69111664D1 (de) | Blutpumpe und Apparat für die extracorporale Blutzirkulation. | |
NO175023C (no) | Fremgangmåte for in vitro diagnostisering av en innflammasjonssykdom indusert av immunkomplekser som er i omlöp, og fremgangsmåte for fremstilling av dsRNA til den in vitro diagnostisering | |
ATE209684T1 (de) | Dna-sequenzen für matrix-metallproteasen, ihre herstellung und verwendung | |
DE3782346D1 (de) | Verwendung von chinolon und naphthyridin-antibiotika zur herstellung von ophthalmischen arzneimitteln. | |
ATE6032T1 (de) | Biologisch aktive substanzen, deren herstellung aus menschlichem kasein und zubereitungen, die sie enthalten. | |
HU901641D0 (en) | Polymerized antibodies and process for their production | |
ATE84877T1 (de) | Verfahren zur kristallmorphologischen blut- und harnanalyse, zur fruehdiagnose und zur herstellung von arzneimitteln. | |
ATE202799T1 (de) | Hybride proteinkomplexe, betreffendes herstellungsverfahren, und ihre anwendungen in der diagnostik, als therapeutische agens oder reaktionsmittel, das in der medizin verwendung findet | |
DE3585061D1 (de) | Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnose- oder therapieverfahren bezueglich krebskrankheiten. | |
EP0339163A3 (en) | Monoclonal antibodies specific for hiv and hybridomas for their production | |
KR950702207A (ko) | Tlp 복합체에 대한 항원성 부위와 이의 항체(antigenic regions of tumour-liberated particles (tlp) complexes and antibodies against them) | |
Miller et al. | The painful prescription: a procrustean perspective? | |
Ribeiro et al. | Eosinophilic leukaemia with trisomy 8 and double gammopathy. | |
ATE172449T1 (de) | Biphenyl jodierte derivate und ihre verwendung als diagnostikum | |
Awad et al. | Diagnostic criteria as a predictor of drug response in schizophrenia. | |
DE68922686D1 (de) | Zyklische, Stickstoff enthaltende Liganden, ihre Metallkomplexe, diese enthaltende Diagnostik-Mittel und Verfahren zur Herstellung der Liganden. | |
Garvey et al. | Changes in urinary MHPG during treatment of depression with imipramine. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee |